Яков Беркун

Научные публикации

• 2023 ACR/EULAR antiphospholipid syndrome classification criteria
• The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
• Tofacitinib-induced progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome
• Platelet count and risk of severe illness in hospitalised children with Influenza-Like illness
• Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement
• Pediatric respiratory admissions and related viral infections during the COVID-19 pandemic
• Bullous Hemorrhagic Target Lesions in IgA Leukocytoclastic Vasculitis
• Risk factors for haemodynamic compromise in multisystem inflammatory syndrome in children: a multicentre retrospective study
• Multisystem inflammatory syndrome in children associated with COVID-19 presenting as cervical inflammation
• Obstacles in Early Diagnosis of Children With Juvenile Idiopathic Arthritis: A Nationwide Israeli Retrospective Study
• Case Series of Myocarditis Following mRNA COVID Vaccine Compared to Pediatric Multisystem Inflammatory Syndrome: Multicenter Retrospective Study
• Sechs Fälle von Pityriasis rosea nach SARS-CoV-2-Impfung mit BNT162b2
• Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2
• Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases
• Increased prevalence of attention-deficit hyperactivity disorder symptomatology in patients with familial Mediterranean fever
• Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings
• Discontinuation of Colchicine Therapy in Children With Familial Mediterranean Fever
• Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel
• Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
• Hijab Pin Ingestions
• OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death
• Pyogenic sacroiliitis in children: don't forget the very young
• Japanese scoring systems to predict resistance to intravenous immunoglobulin in Kawasaki disease were unreliable for Caucasian Israeli children
• JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
• A high and equal prevalence of the Q703K variant in NLRP3 patients with autoinflammatory symptoms and ethnically matched controls
• Adenosine Deaminase 2 Deficiency: More Than Monogenic Vasculitis
• High-dose aspirin for Kawasaki disease: outdated myth or effective aid?
• Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation
• Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency
• Familial Mediterranean fever
• Update on Auto-Inflammatory Diseases and Familial Mediterranean Fever
• Behçet's disease and cerebral sinus vein thrombosis in children: a case study and review of the literature
• Sudden onset unexplained encephalopathy in infants: think of cannabis intoxication
• Efficacy of Rituximab in Refractory Cold Agglutinin Hemolytic Anemia in a Patient with Ataxia-Telangiectasia
• Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab
• Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
• Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency
• Seasonality of birth of patients with juvenile idiopathic arthritis
• Iatrogenic Cushing Syndrome due to Intranasal Dexamethasone
• Disturbed B and T cell homeostasis and neogenesis in patients with ataxia telangiectasia
• Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
• Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy
• Diagnosis and classification of juvenile idiopathic arthritis
• Diagnostic criteria of familial Mediterranean fever
• Familial Mediterranean fever: a critical digest of the 2012-2013 literature
• The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy
• Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis
• Chronic chilblains: the clinical presentation and disease course in a large paediatric series
• Dermatologic manifestations of ataxia-telangiectasia syndrome
• Pharmacokinetics of colchicine in pediatric and adult patients with familial Mediterranean fever
• Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis
• FMF - clinical features, new treatments and the role of genetic modifiers: a critical digest of the 2010-2012 literature
• Colchicine is a safe drug in children with familial Mediterranean fever
• Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions
• Cellular interactions of synovial fluid γδ T cells in juvenile idiopathic arthritis
• NOD2/CARD15 gene mutations in patients with familial Mediterranean fever
• Impact of persistent antiphospholipid antibodies on risk of incident symptomatic thromboembolism in children: a systematic review and meta-analysis
• The relative contribution of environmental and genetic factors to phenotypic variation in familial Mediterranean fever (FMF)
• T-cell compartment in synovial fluid of pediatric patients with JIA correlates with disease phenotype
• Cellular and clinical report of new Griscelli syndrome type III cases
• Children with oligoarticular juvenile idiopathic arthritis are at considerable risk for growth retardation
• Neurologic presentation in children with ataxia-telangiectasia: is small head circumference a hallmark of the disease?
• GammadeltaT cells in juvenile idiopathic arthritis: higher percentages of synovial Vdelta1+ and Vgamma9+ T cell subsets are associated with milder disease
• The familial Mediterranean fever gene as a modifier of periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome
• The feasibility and validity of forced spirometry in ataxia telangiectasia
• Role of the R92Q TNFRSF1A mutation in patients with familial Mediterranean fever
• EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria
• Familial Mediterranean Fever in the first two years of life: a unique phenotype of disease in evolution
• Familial Mediterranean fever in children presenting with attacks of fever alone
• Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?
• TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function
• Reversible airway obstruction in children with ataxia telangiectasia
• Familial Mediterranean fever in Ashkenazi Jews: the mild end of the clinical spectrum
• Environmental factors and the geoepidemiology of juvenile idiopathic arthritis
• Common infectious agents prevalence in antiphospholipid syndrome
• Infectious antibodies in systemic lupus erythematosus patients
• Is E148Q a benign polymorphism or a disease-causing mutation?
• Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease
• The Ped-APS Registry: the antiphospholipid syndrome in childhood
• Clinical disease among patients heterozygous for familial Mediterranean fever
• MEFV mutation carriage in Israeli Jewish individuals from ethnicities with low risk for familial Mediterranean fever
• Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus
• Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry
• Intracardiac thrombus and pulmonary aneurysms in an adolescent with Behçet disease
• Differentiation of post-streptococcal reactive arthritis from acute rheumatic fever
• Periodic fever accompanied by aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA syndrome) in adults
• Epigenetic inheritance of DNA methylation limits activation-induced expression of FOXP3 in conventional human CD25-CD4+ T cells
• Neuropsychiatric lupus and infectious triggers
• Acute otitis media in the first two months of life: characteristics and diagnostic difficulties
• Pediatric antiphospholipid syndrome
• The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008
• The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008
• The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008
• Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience
• Protracted febrile myalgia in children and young adults with familial Mediterranean fever: analysis of 15 patients and suggested criteria for working diagnosis
• Pyrin and cryopyrin--similar domain sequence but opposite inflammatory consequence
• Auto-inflammatory fever syndromes
• 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis
• A single testing of serum amyloid a levels as a tool for diagnosis and treatment dilemmas in familial Mediterranean fever
• The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations
• Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus
• Peritoneal adhesions and intestinal obstructions in patients with familial Mediterranean fever--are they more frequent?
• alpha1beta1 Integrin+ and regulatory Foxp3+ T cells constitute two functionally distinct human CD4+ T cell subsets oppositely modulated by TNFalpha blockade
• Antiphospholipid syndrome and recurrent thrombosis in children
• Use of complementary and alternative medicine among patients attending rheumatology clinics in Israel
• Perceived efficacy among patients of various methods of complementary alternative medicine for rheumatologic diseases
• Pemphigus following hepatitis B vaccination--coincidence or causality?
• Autoimmune hepatitis: a part of the antiphospholipid syndrome?
• Sludge ball, pseudolithiasis, cholelithiasis and choledocholithiasis from intrauterine life to 2 years: a 13-year follow-up
• Heparin-induced recurrent anaphylaxis
• The outcome of pregnancy in the wives of men with familial mediterranean fever treated with colchicine
• Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene
• Kingella kingae endocarditis and sepsis in an infant
• Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis
• Risk factors for cranial ischemic complications in giant cell arteritis
• Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery
• Knowledge and expectations of patients receiving aeroallergen immunotherapy
• Evaluation of adverse reactions to local anesthetics: experience with 236 patients
• Intestinal protein loss and hypoalbuminemia in children with pneumonia
• A man with swollen calf and discoloration of the foot
• Evidence that Griscelli syndrome with neurological involvement is caused by mutations in RAB27A, not MYO5A
• Anti-IgE--a new treatment for allergic diseases
• Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitor
• Leukotriene antagonists: additional treatment for chronic urticaria?
• Successful treatment of delayed pressure urticaria with montelukast
• Focal bacterial nephritis (lobar nephronia) in children
• A new mutation in the CFTR gene, composed of two adjacent DNA alterations, is a common cause of cystic fibrosis among Georgian Jews
• Urticaria in patients with hepatitis A virus infection